Teladoc Health (TDOC) Stock Analysis: Sell TDOC After Q4 Earnings?

This content was made for video and podcast format:



Last night Teladoc Health (#TDOC) released their Q4 earnings and failed to impress investors. The company reported GAAP EPS of -$3.07 (miss by $2.82) and revenue of $383.3M (+144.9% Y/Y/).

Although revenues were up dramatically, #Teladoc wasn't able to increase them without also dramatically increasing expenses. A fiscal 2021 outlook was also given which proved to be anything but exciting. The company is expecting total U.S. paid membership to fall in line with 2020 numbers as well as total visits. Shares of Teladoc are up +122% over the past year because investors were betting on growth. The company certainly grew over the past year, but has that growth flattened out?

Create a Webull account and recieve 2 FREE stocks

Create a FREE TradingView account and start charting your technical analysis

Follow me on Twitter to get real-time trade ideas and updates

Contact me if you have any questions or inquiries

Thanks to the TDOC website for the photo of CEO Jason Gorevic